This trial will study how the medicine PF-06821497 is processed by the body when taken in two different forms and with/without food.
2 Primary · 16 Secondary · Reporting Duration: 0 (pre-dose), 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 36, and 48 hours post-dose
Awards & Highlights
3 Treatment Groups
Part 1: PF-06821497 Sequence 2
1 of 3
Part 1: PF-06821497 Sequence 1
1 of 3
Part 2: PF-06821497 Sequence 1
1 of 3
18 Total Participants · 3 Treatment Groups
Primary Treatment: Part 1: PF-06821497 Sequence 2 · No Placebo Group · Phase 1
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Age 18 - 55 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What deleterious effects has Part 1: PF-06821497 Sequence 2 been found to have on humans?
"Our power team has assigned the safety of Part 1: PF-06821497 Sequence 2 a score of 1, as this is an initial Phase 1 trial with limited data on its efficacy and security." - Anonymous Online Contributor
Is there ongoing recruitment for this experiment?
"According to the clinicaltrials.gov listing, this study is not actively seeking enrolment at present. The trial was initially advertised on March 18th 2023 and its last edit occurred a day before that; however, 823 other trials are currently open for participation." - Anonymous Online Contributor
Who is eligible to be enrolled in this research study?
"This clinical trial has a set of eligibility criteria that requires participants to be in good health and within the age range of 18-55. Currently, approximately eighteen individuals are being accepted into this research endeavour." - Anonymous Online Contributor
Are applicants above thirty years of age eligible for this research experiment?
"This study can accept patients aged 18 to 55 as indicated by the eligibility criteria. Other trials are available for those younger than 18 and older than 65, with 54 studies open to minors and 368 catered towards seniors." - Anonymous Online Contributor